Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bristol-Myers Squibb Co (BMY)  
$49.20 0.05 (0.1%) as of 4:30 Fri 11/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,250,000,000
Market Cap: 110.70(B)
Last Volume: 6,187,103 Avg Vol: 12,268,106
52 Week Range: $42.6 - $63.11
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 100     S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  243
Guru Rank Value     : 6.6
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 8,073 11,903
Total Buy Value $0 $0 $412,311 $611,926
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 3 5
Total Shares Sold 56,000 56,378 56,475 57,175
Total Sell Value $2,650,480 $2,667,199 $2,670,901 $2,709,832
Total People Sold 1 2 3 4
Total Sell Transactions 1 2 3 4
End Date 2025-08-31 2025-05-30 2024-11-29 2023-11-30

   
Records found: 834
  Page 1 of 34  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Meyers Gregory Scott EVP, Chief Digital & Tech Off.   •       –      –    2025-11-01 4 D $46.07 $122,777 D/D (2,665) 19,718     -
   Meyers Gregory Scott EVP, Chief Digital & Tech Off.   •       –      –    2025-11-01 4 OE $0.00 $0 D/D 6,281 22,383     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-11-01 4 D $46.07 $57,035 D/D (1,238) 1,182     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-11-01 4 D $0.00 $0 D/D (544) 2,420     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-11-01 4 OE $0.00 $0 D/D 2,964 2,964     -
   Shanahan Karin EVP, Chief Supply Chain & Ops   •       –      –    2025-11-01 4 D $46.07 $148,023 D/D (3,213) 16,865     -
   Shanahan Karin EVP, Chief Supply Chain & Ops   •       –      –    2025-11-01 4 OE $0.00 $0 D/D 6,281 20,078     -
   Gallman Cari EVP, General Counsel   •       –      –    2025-10-02 4 D $45.73 $106,642 D/D (2,332) 11,066     -
   Gallman Cari EVP, General Counsel   •       –      –    2025-10-02 4 OE $0.00 $0 D/D 4,558 13,398     -
   Elkins David V EVP, Chief Financial Officer   •       –      –    2025-09-02 4 AS $47.33 $2,650,480 D/D (56,000) 167,379 4%     
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-09-01 4 D $47.18 $29,818 D/D (632) 5,669     -
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-09-01 4 OE $0.00 $0 D/D 1,235 6,301     -
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-08-02 4 S $44.23 $16,719 D/D (378) 5,066 -8%     
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-08-02 4 OE $0.00 $0 D/D 738 5,444     -
   Gallman Cari EVP, General Counsel   •       –      –    2025-08-01 4 D $44.23 $24,017 D/D (543) 8,840     -
   Gallman Cari EVP, General Counsel   •       –      –    2025-08-01 4 OE $0.00 $0 D/D 1,061 9,383     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-06-13 4 GA $0.00 $0 I/I 62,719 125,439     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-06-13 4 GD $0.00 $0 D/D 62,719 0     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-06-03 4 GA $0.00 $0 I/I 62,720 62,720     -
   Boerner Christopher S. Chief Executive Officer   •       •      –    2025-06-03 4 GD $0.00 $0 D/D 62,720 62,719     -
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-06-03 4 D $48.09 $160,332 D/D (3,334) 4,706     -
   Short Bartie Wendy EVP, Corporate Affairs   •       –      –    2025-06-03 4 OE $0.00 $0 D/D 8,040 8,040     -
   Hickey Benjamin President, RayzeBio Org.   •       –      –    2025-05-09 4 S $38.01 $3,702 I/I (97) 0 2%     
   Hirawat Samit EVP,Chief Med.Offr.,Drug Dev.   •       –      –    2025-04-25 4 B $47.58 $202,215 D/D 4,250 83,513 2.74 -3%     
   Shanahan Karin EVP, Glob. Prod. Dev. & Supply   •       –      –    2025-04-01 4 D $59.55 $100,759 D/D (1,692) 13,797     -
  834 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 34
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us